Handspring Health Raises $19M Series B Led by RPS Ventures

Mental health has become one of healthcare's defining infrastructure challenges, especially for children and young adults. Demand continues to outpace available clinicians, families still face long waits, and too many young patients never receive treatment. Against that backdrop, Handspring Health announced a $19M Series B funding round on July 8, 2026, led by RPS Ventures.

Angelini Ventures joined the financing as a new investor alongside returning investors Cobalt Ventures, NextView Ventures, nvp capital, Hyde Park Angels, and Cornucopian Capital. As part of the investment, Sarah Fox of Angelini Ventures will join Handspring Health's board as an observer. The round gives the company more capital to expand its clinician workforce, deepen its Complex Care program, broaden its geographic reach, and continue building the software layer behind its care model.

For the broader digital health market, the announcement is not just another venture round with a neat headline and a polite quote stack. It is a reminder that investors are still willing to back healthcare companies when the model connects access, outcomes, payer alignment, and operational discipline. Optimism alone is no longer closing rounds. Evidence is doing more of the work.

What Happened

Handspring Health was founded in 2021 by Sahil Choudhry, CEO, and Kwasi Kyei, President. The company provides evidence-based behavioral healthcare for children, teens, young adults, and their families through a virtual-first, clinic-enabled model. It focuses on therapy for anxiety, depression, OCD, ADHD, trauma, and related diagnoses, with parent engagement and structured clinical programs built into the care experience.

The company's latest Series B brings its total announced funding to $37.2M, following a $6.2M Seed round and a $12M Series A. Returning investors matter here because they have already seen more than the fundraising narrative. They have seen the operating machinery, the clinical workflow, the payer conversations, and the uncomfortable parts that never make it into the cleanest deck. Their continued participation suggests confidence in execution, not just enthusiasm for a category that looks good on a market map.

Why This Matters

Youth mental healthcare remains one of the largest unmet needs in the U.S. healthcare system. Handspring Health cites the scale plainly: 1 in 5 children in the United States has a diagnosable mental health disorder, while roughly half of children who need behavioral healthcare do not receive it from a provider. That gap is where waitlists, insurance friction, clinician shortages, and family exhaustion all meet in one very expensive lobby.

Handspring Health has built its business around addressing those barriers through an insurance-aligned model rather than a cash-pay product dressed up as access. The company reports that 96% of families experience improvement in daily life at discharge, 84% of anxiety patients improve on validated clinical scales, and 79% of depression patients improve on validated clinical scales. It also reports a Net Promoter Score of 82, which is not a clinical outcome by itself but does suggest families find the experience valuable enough to recommend.

Market Context

Digital mental health pulled in enormous attention over the last several years, but capital has become more selective. Investors are asking harder questions about clinical quality, utilization, unit economics, payer relationships, and whether software actually improves care delivery or simply makes the waiting room look more modern. Handspring Health appears aligned with that reset because it treats technology as infrastructure for care, not as a substitute for care.

That distinction matters. Healthcare companies rarely win because they built another application. They win when they solve operational problems that patients, clinicians, payers, and families feel every day. Handspring Health's model combines salaried clinicians, evidence-based treatment, insurance relationships, family engagement, and software-enabled workflows. In a sector with plenty of noise, that is a more durable story than another dashboard promising to fix everyone by Tuesday.

Competitive Landscape

Handspring Health differentiates itself by focusing specifically on pediatric and young adult behavioral health while integrating families directly into treatment. Its care model includes evidence-based therapy programs, parent coaching, and specialized services such as its Complex Care program for higher-acuity youth. The company is also investing in proprietary software and AI-supported clinical tools designed to reduce administrative burden and improve care coordination.

The company's December 2025 acquisition of Joon Care expanded its capabilities and geographic presence while adding payer relationships in Washington state. That deal matters because Handspring Health has described the acquisition as the first step in a broader expansion strategy. In other words, this is not just a company adding states one press release at a time. It is trying to build a larger behavioral health platform around clinical quality, payer access, and repeatable operating systems.

Leadership has also expanded beyond the founding team. Amy Kranzler, PhD serves as Chief Clinical Officer, Megan Martino, LCSW leads Clinical Operations, and Daniel Kim oversees Growth. That kind of operating depth matters in healthcare because scaling care is not the same thing as scaling a SaaS workflow. More clinicians, more states, more payers, and greater patient acuity all create complexity that punishes shallow management teams quickly.

What This Signals

The Handspring Health financing reflects a broader shift across healthcare venture capital. Capital is moving toward companies that can demonstrate measurable outcomes, payer alignment, and operational discipline. Investors want models that improve access while producing evidence that the model works in practice, not simply in theory.

For founders across digital health, the lesson extends beyond fundraising. Strong clinical performance, trusted payer relationships, and repeatable execution create advantages that are difficult to replicate with marketing alone. The companies still raising meaningful rounds are usually the ones that can show the difference between adoption and impact.

RPS Ventures' decision to lead the round, alongside participation from returning investors and Angelini Ventures, reinforces that trend. Investors continue rewarding businesses that pair clinical outcomes with operational execution instead of relying on category momentum alone.

The Bigger Industry Shift

Behavioral healthcare is moving toward integrated, technology-enabled models that emphasize measurable outcomes instead of digital convenience by itself. Families do not need another interface that confirms the system is overwhelmed. They need care that starts sooner, fits insurance realities, supports clinicians, and produces progress that can be measured with something better than vibes.

Handspring Health's latest round shows that venture capital remains available for healthcare companies solving structural problems with evidence-based execution. In a market where capital has become less forgiving, measurable outcomes have become one of the strongest competitive advantages a healthcare company can possess. That is the real signal inside the Series B: funding is still available, but the bar is getting more honest.